This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Darzalex
  • /
  • A Study Comparing Daratumumab, Lenalidomide, and D...
Clinical trial

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Read time: 2 mins
Last updated:23rd May 2014
Identifier: NCT02076009
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest